Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2915 ARTíCULOS , VIENDO DEL 2866 AL 2880

PUBMED

Review on initial drug treatment in Parkinson's disease did not mention entacapone.

Elrington GM.

BMJ. 2015 Nov 3;351:h5843. doi: 10.1136/bmj.h5843. No abstract available.

0

0

0

PUBMED

Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.

Huang YT, Georgiev D, Foltynie T, Limousin P, Speekenbrink M, Jahanshahi M.

Neuropsychologia. 2015 Aug;75:577-87. doi: 10.1016/j.neuropsychologia.2015.07.012.

0

0

0

PUBMED

Effect of acupuncture on gait in Parkinson's disease: a case report.

Fukuda S, Egawa M.

Acupunct Med. 2015 Aug;33(4):325-8. doi: 10.1136/acupmed-2015-010760.

0

0

0

PUBMED

Association of the rs1801133 variant in the MTHFR gene and sporadic Parkinson's disease.

García S, Coral-Vázquez R, Gallegos-Arreola MP, Montes-Almanza LA, Canto P, García-Martínez FA, Chavira-Hernández G, Palma-Flores C, Dávila-Maldonado L, Cuevas-García CF, López Hernández LB.

Folia Neuropathol. 2015;53(1):24-8.

0

0

0

PUBMED

Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.

Simon DK, Simuni T, Elm J, Clark-Matott J, Graebner AK, Baker L, Dunlop SR, Emborg M, Kamp C, Morgan JC, Ross GW, Sharma S, Ravina B; NINDS NET-PD Investigators..

J Parkinsons Dis. 2015;5(4):731-6. doi: 10.3233/JPD-150666.

0

0

0

PUBMED

Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease.

Keane H, Ryan BJ, Jackson B, Whitmore A, Wade-Martins R.

Sci Rep. 2015 Nov 26;5:17004. doi: 10.1038/srep17004.

0

0

0

PUBMED

REM sleep behavior disorder and neuropathology in Parkinson's disease.

Postuma RB, Adler CH, Dugger BN, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Jacobson SA, Belden CM, Sue LI, Serrano G, Beach TG.

Mov Disord. 2015 Sep;30(10):1413-7. doi: 10.1002/mds.26347.

0

0

0

PUBMED

Lysosomes to combat Parkinson's disease.

Isacson O.

Nat Neurosci. 2015 Jun;18(6):792-3. doi: 10.1038/nn.4027. No abstract available.

0

0

0

PUBMED

Cognitive decline in Parkinson disease: How steep and crowded is the slope?

Hershey LA, Peavy GM.

Neurology. 2015 Oct 13;85(15):1268-9. doi: 10.1212/WNL.0000000000002003. No abstract available.

0

0

0

PUBMED

Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.

Szeto JY, Mowszowski L, Gilat M, Walton CC, Naismith SL, Lewis SJ.

Parkinsonism Relat Disord. 2015 Jan;21(1):31-5. doi: 10.1016/j.parkreldis.2014.10.020.

0

0

0

PUBMED

Preferences of patients with Parkinson's disease for communication about advanced care planning.

Tuck KK, Brod L, Nutt J, Fromme EK.

Am J Hosp Palliat Care. 2015 Feb;32(1):68-77. doi: 10.1177/1049909113504241.

0

0

0

PUBMED

The transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's disease.

Razgado-Hernandez LF, Espadas-Alvarez AJ, Reyna-Velazquez P, Sierra-Sanchez A, Anaya-Martinez V, Jimenez-Estrada I, Bannon MJ, Martinez-Fong D, Aceves-Ruiz J.

PLoS One. 2015 Feb 18;10(2):e0117391. doi: 10.1371/journal.pone.0117391.

0

0

0

PUBMED

Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.

Tsika E, Nguyen AP, Dusonchet J, Colin P, Schneider BL, Moore DJ.

Neurobiol Dis. 2015 May;77:49-61. doi: 10.1016/j.nbd.2015.02.019.

0

0

0

PUBMED

The non-motor heterogeneity of Parkinson disease.

Erro R.

Neurol Sci. 2015 Sep;36(9):1705-6. doi: 10.1007/s10072-015-2233-y. No abstract available.

0

0

0

PUBMED

Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype.

Galna B, Lord S, Burn DJ, Rochester L.

Mov Disord. 2015 Mar;30(3):359-67. doi: 10.1002/mds.26110.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy